Literature DB >> 9765437

Role of glutamine 17 of the bovine papillomavirus E5 protein in platelet-derived growth factor beta receptor activation and cell transformation.

O Klein1, G W Polack, T Surti, D Kegler-Ebo, S O Smith, D DiMaio.   

Abstract

The bovine papillomavirus E5 protein is a small, homodimeric transmembrane protein that forms a stable complex with the cellular platelet-derived growth factor (PDGF) beta receptor through transmembrane and juxtamembrane interactions, resulting in receptor activation and cell transformation. Glutamine 17 in the transmembrane domain of the 44-amino-acid E5 protein is critical for complex formation and receptor activation, and we previously proposed that glutamine 17 forms a hydrogen bond with threonine 513 of the PDGF beta receptor. We have constructed and analyzed mutant E5 proteins containing all possible amino acids at position 17 and examined the ability of these proteins to transform C127 fibroblasts, which express endogenous PDGF beta receptor. Although several position 17 mutants were able to transform cells, mutants containing amino acids with side groups that were unable to participate in hydrogen bonding interactions did not form a stable complex with the PDGF beta receptor or transform cells, in agreement with the proposed interaction between position 17 of the E5 protein and threonine 513 of the receptor. The nature of the residue at position 17 also affected the ability of the E5 proteins to dimerize. Overall, there was an excellent correlation between the ability of the various E5 mutant proteins to bind the PDGF beta receptor, lead to receptor tyrosine phosphorylation, and transform cells. Similar results were obtained in Ba/F3 hematopoietic cells expressing exogenous PDGF beta receptor. In addition, treatment of E5-transformed cells with a specific inhibitor of the PDGF receptor tyrosine kinase reversed the transformed phenotype. These results confirm the central importance of the PDGF beta receptor in mediating E5 transformation and highlight the critical role of the residue at position 17 of the E5 protein in the productive interaction with the PDGF beta receptor. On the basis of molecular modeling analysis and the known chemical properties of the amino acids, we suggest a structural basis for the role of the residue at position 17 in E5 dimerization and in complex formation between the E5 protein and the PDGF beta receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9765437      PMCID: PMC110309     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells.

Authors:  L A Nilson; R L Gottlieb; G W Polack; D DiMaio
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

Review 2.  Virocrine transformation.

Authors:  D Drummond-Barbosa; D DiMaio
Journal:  Biochim Biophys Acta       Date:  1997-02-22

3.  Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.

Authors:  L M Petti; V Reddy; S O Smith; D DiMaio
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling.

Authors:  D Drummond-Barbosa; R R Vaillancourt; A Kazlauskas; D DiMaio
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

5.  Codon cassette mutagenesis: a general method to insert or replace individual codons by using universal mutagenic cassettes.

Authors:  D M Kegler-Ebo; C M Docktor; D DiMaio
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

6.  Cellular transformation by a transmembrane peptide: structural requirements for the bovine papillomavirus E5 oncoprotein.

Authors:  A N Meyer; Y F Xu; M K Webster; A E Smith; D J Donoghue
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

7.  Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants.

Authors:  J Sparkowski; J Anders; R Schlegel
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.

Authors:  M Kovalenko; A Gazit; A Böhmer; C Rorsman; L Rönnstrand; C H Heldin; J Waltenberger; F D Böhmer; A Levitzki
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

9.  E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.

Authors:  J Sparkowski; M Mense; J Anders; R Schlegel
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein.

Authors:  A Staebler; J H Pierce; S Brazinski; M A Heidaran; W Li; R Schlegel; D J Goldstein
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

View more
  19 in total

1.  Productive interaction between transmembrane mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor beta receptor.

Authors:  Char-Chang Lai; Anne P B Edwards; Daniel DiMaio
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Dislocation of a type I membrane protein requires interactions between membrane-spanning segments within the lipid bilayer.

Authors:  Brendan N Lilley; Domenico Tortorella; Hidde L Ploegh
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

3.  A single amino acid substitution converts a transmembrane protein activator of the platelet-derived growth factor β receptor into an inhibitor.

Authors:  Lisa M Petti; Kristina Talbert-Slagle; Megan L Hochstrasser; Daniel DiMaio
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

4.  Compensatory mutants of the bovine papillomavirus E5 protein and the platelet-derived growth factor β receptor reveal a complex direct transmembrane interaction.

Authors:  Anne P B Edwards; Yanhua Xie; Lara Bowers; Daniel DiMaio
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

5.  Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor.

Authors:  Kristina Talbert-Slagle; Sara Marlatt; Francisco N Barrera; Ekta Khurana; Joanne Oates; Mark Gerstein; Donald M Engelman; Ann M Dixon; Daniel Dimaio
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

6.  Bovine papillomavirus E5 protein induces oligomerization and trans-phosphorylation of the platelet-derived growth factor beta receptor.

Authors:  C C Lai; C Henningson; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

7.  Two transmembrane dimers of the bovine papillomavirus E5 oncoprotein clamp the PDGF β receptor in an active dimeric conformation.

Authors:  Alexander G Karabadzhak; Lisa M Petti; Francisco N Barrera; Anne P B Edwards; Andrés Moya-Rodríguez; Yury S Polikanov; J Alfredo Freites; Douglas J Tobias; Donald M Engelman; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

Review 8.  The bovine papillomavirus E5 protein and the PDGF beta receptor: it takes two to tango.

Authors:  Kristina Talbert-Slagle; Daniel DiMaio
Journal:  Virology       Date:  2008-11-06       Impact factor: 3.616

9.  In vitro dimerization of the bovine papillomavirus E5 protein transmembrane domain.

Authors:  Joanne Oates; Matthew Hicks; Timothy R Dafforn; Daniel DiMaio; Ann M Dixon
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

10.  Influenza virus activates inflammasomes via its intracellular M2 ion channel.

Authors:  Takeshi Ichinohe; Iris K Pang; Akiko Iwasaki
Journal:  Nat Immunol       Date:  2010-04-11       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.